This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

CVS-Caremark Split Could Drive Up Stock: Analyst

Stocks in this article: CVS

NEW YORK ( TheStreet) -- A breakup between CVS (CVS)and its Caremark unit could present a big upside for the stock, according to an analyst.

If the two divisions were to split, it could mean as much as 30% upside for the stock, Credit Suisse analyst Edward Kelly wrote in a note.

But just how likely is a split between CVS and Caremark? Kelly noted that if Caremark's performance doesn't improve over the next year it could be highly likely.

"We find CVS's continued mismanagement of Caremark and its lack of insight into the underlying issues disturbing," he wrote. "That being said, we believe overwhelmingly negative investor sentiment has created a compelling risk/reward set-up in the stock. We continue to believe CVS's problems are fixable."

While Caremark is experiencing some fundamental problems, Kelly still believes it's an attractive asset for a potential buyer. He also said that while a sale would be the best bet for CVS, a spin-off could also help the drugstore.

In its fourth quarter, CVS reported lower profits and revenue and said it expects profit at its Caremark pharmacy benefits management to shrink further in 2011. This will mark the second consecutive year of profit declines at the division.

Wall Street expected the company would begin to see improvements at Caremark, but CVS said a new multi-year contract with Aetna will drag on results.

Other issues affecting Caremark include lower payments from pharmacy benefits programs for federal employees, less profitable contract renewals, and expenses related to cost cuts. CVS also said adjusted profit per prescription will continue to decline, moving closer to the levels reported by Caremark's competitors.

The company does expect Caremark profit to start to grow in 2012.

CVS acquired Caremark in 2007 for $27 billion.

--Written by Jeanine Poggi in New York.



>To contact the writer of this article, click here: Jeanine Poggi.

>To follow the writer on Twitter, go to http://twitter.com/jpoggi.

>To submit a news tip, send an email to: tips@thestreet.com.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,168.01 +193.70 1.14%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,549.4880 +0.2620 0.01%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs